About 800 reports

Oligodendroglioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Oligodendroglioma – Drugs In Development, 2022, provides an overview of the Oligodendroglioma (Oncology) pipeline...

  • Cancer
  • Targeted Therapy
  • Oncology
  • Therapy
  • Drug Development
  • World

Oncology information systems manage data from various treatment schedules, treatment plans, and treatment delivery for each patient.Focus on laying a framework on standardization in OIS is further advancing the level of care for each cancer patient through a multidisciplinary approach. Factors such as increasing adoption of OIS solutions...

  • Healthcare
  • Patient Data Management
  • Oncology
  • Oncology
  • United States
  • World
  • North America
  • Europe
  • APAC
  • Medical Technology Density
  • Cancer Incidence

Community Oncology Services Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change provides the strategists; marketers and senior management with the critical information they need to assess the global community oncology services market as it emerges from the COVID 19 shut down. Description: Where...

  • Oncology
  • Oncology
  • World
  • APAC
  • Health Expenditure
  • Gross Domestic Product Per Capita

Interventional Oncology Devices Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global interventional oncology devices market as it emerges from the COVID-19 shut down. Description: Where is the largest...

  • Oncology
  • Oncology
  • World
  • Gross Domestic Product Per Capita
  • Health Expenditure

Immuno-Oncology Drugs Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global immuno-oncology drugs market as it emerges from the COVID 19 shut down. Description: Where is the largest and fastest growing...

  • Oncology
  • World
  • Private Health Expenditure
  • Public Health Expenditure

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic...

  • Cancer
  • Pharmaceutical
  • Therapy
  • Oncology
  • World
  • Industrial Production

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Serine/Threonine Protein Kinase Pim...

  • Pharmaceutical
  • Oncology
  • Healthcare IT
  • World

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) pipeline Target constitutes...

  • Cancer
  • Pharmaceutical
  • Leukemia
  • Oncology
  • World

The global interventional oncology market size is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2020, at a CAGR of 6.8%. Factors such as the technological advancements in the market are propelling the growth of the interventional oncology market. Additionally, rising cases of surgeries, investments from both private and...

  • Oncology
  • Oncology
  • United States
  • APAC
  • Latin America
  • Cancer Incidence
  • Health Expenditure

The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4billion in 2021, at a CAGR of 12.5% during the forecast period. Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies....

  • Oncology
  • United States
  • APAC
  • Europe
  • North America
  • Latin America
  • Africa
  • Middle East
  • Cancer Incidence
  • Health Expenditure

Myc Proto Oncogene Protein - Drugs In Development, 2021 Summary Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) pipeline Target constitutes close to 23 molecules. Out of which approximately 18 molecules are developed by companies and remaining...

  • Cancer
  • Pharmaceutical
  • Oncology
  • World
  • Industrial Production

The Global Oncology Information Systems Market size is expected to reach $3.4 billion by 2028, rising at a market growth of 7.4% CAGR during the forecast period. The Oncology Information System assists healthcare facilities like hospitals, clinics, and research labs not only in managing and optimizing cancer care solutions, but also...

  • Oncology
  • Oncology
  • World
  • Cancer Incidence
  • Physical Activity Participation Rate

The Global Interventional Oncology Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 6.2% CAGR during the forecast period. Interventional oncology (IO) is an emerging subspecialty that emphasizes on using image-guided processes (diagnostics/surgeries) to improve cancer therapy. Along with surgery, medication,...

  • Oncology
  • Cancer
  • World
  • APAC
  • Health Expenditure
  • Diagnostic Imaging Density

Major companies in the oncology drugs market include F.Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences Inc., Bayer AG and Takeda Pharmaceticals. The global oncology drugs market is expected to grow from $199.95 billion in 2021 to $223.21 billion in 2022 at a compound annual growth rate (CAGR) of 11.6%. The growth is mainly due...

  • Cancer
  • Oncology
  • World
  • Western Europe
  • Oncology Drug Sales

Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Drugs In Development, 2022, provides an overview of the Chemotherapy Induced...

  • Pharmaceutical
  • Blood Disease
  • Chemotherapy
  • World
  • Drug Approval
  • Mortality Rate

Major players in the oncology biosimilars market are Biocoin, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., STADA Arzneimittel AG, Pfizer Inc., Apotex Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, BIOCAD, Amgen, Hospira, F Hoffmann-La Roche, Baxter, Sanofi, Mylan and F Hoffmann-La Roche. The...

  • Oncology
  • World
  • Middle East
  • India
  • United States
  • APAC
  • Prescription Drug Sales
  • Biologics Patents Registrations

Major players in the immuno-oncology drugs market are Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG and AbbVie Inc. The global immuno-oncology drugs market is expected to grow from $60.32 billion in 2021...

  • Oncology
  • World
  • Cancer Incidence
  • Cancer Mortality

Report Scope: The current report provides detailed exposure of global monoclonal antibodies for the oncology market.This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market’s drivers, challenges, and opportunities. The...

  • Monoclonal Antibody
  • World
  • Cancer Incidence

Oncology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global oncology drugs market. Description: Where is the largest and fastest growing market for the oncology...

  • Oncology
  • World
  • APAC
  • Health Expenditure
  • Drug Approval

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...

  • Oncology
  • World
  • Fuel Demand
  • Health Expenditure

Anaplastic Oligoastrocytoma - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma - Pipeline Review, H2 2020, provides an overview of the Anaplastic Oligoastrocytoma (Oncology) pipeline landscape. Anaplastic oligoastrocytoma...

  • Cancer
  • Therapy
  • Oncology
  • Pharmaceutical
  • Drug Development
  • Cell Therapy
  • Biotechnology
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Global Interventional Oncology Devices Market to Reach $ 7,861.1 Million by 2030 Market Report Coverage - Interventional Oncology Devices Market Segmentation • Cancer Type – Liver Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, and Other Cancers • End User – Hospitals, Ambulatory...

  • Oncology
  • Oncology
  • World
  • Cancer Incidence
  • Surgical Procedures Performed

Oncology/Cancer Drugs Market By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), and Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Other Cancers):...

  • Oncology
  • World
  • APAC
  • Europe

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021 Summary According to the recently published report ’SerineThreonine Protein Kinase Pim 2 - Drugs in Development, 2021’; Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto...

  • Pharmaceutical
  • Oncology
  • Healthcare IT
  • World

Gliosarcoma - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma - Pipeline Review, H2 2020, provides an overview of the Gliosarcoma (Oncology) pipeline landscape. Gliosarcoma is a type of brain tumor that originates from glial cells....

  • Therapy
  • Pharmaceutical
  • Oncology
  • World
  • Belgium
  • Pharmaceutical Registrations
  • Drug Approval

Report Scope: The current report highlights the current and future market potential of IO along with a detailed analysis of the competitive environment, regulatory scenario, technology, and the drivers, restraints, opportunities and trends affecting the market.The report also offers market projections to 2026 and market...

  • Diagnostic Imaging
  • Oncology
  • Health Care Provider
  • Oncology
  • World
  • APAC
  • Diagnostic Imaging Density

Major players in the oncology biosimilars market are Biocoin, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., STADA Arzneimittel AG, Pfizer Inc., Apotex Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH and BIOCAD. The global oncology biosimilars market is expected to grow from $2.88 billion...

  • Oncology
  • World
  • India
  • APAC
  • Prescription Drug Sales
  • Biologics Patents Registrations

Major players in the immuno-oncology drugs market are Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, and AbbVie Inc. The global immuno-oncology drugs market is expected to grow from $57.28 billion in 2020...

  • Oncology
  • World
  • Cancer Incidence
  • Cancer Mortality

Report Scope: This report aims to provide a comprehensive study of the global market for oncology pharmaceuticals (cancer drugs).It provides a detailed description of the different oncology pharmaceutical types (targeted therapy, immunotherapy, chemotherapy and hormone therapy) and current and historical market revenues. The...

  • Pharmaceutical
  • Oncology
  • Cancer
  • World
  • Cancer Incidence
  • Drug Approval

Oligodendroglioma - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Oligodendroglioma - Pipeline Review, H2 2020, provides an overview of the Oligodendroglioma (Oncology) pipeline landscape. Oligodendroglioma is a type of glioma (primary...

  • Therapy
  • Cancer
  • Oncology
  • Oncology
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations
  • Drug Approval